Most Active InvestorsFind investorsPricing
Start for free
Start for free
QB Capital logo

QB Capital

Asia, Fukuoka, Japan, Fukuoka

Description

QB Capital focuses on venture capital business.

Investor Profile

QB Capital has backed more than 11 startups, with 5 new investments in the last 12 months alone. The firm has led 2 rounds, about 18% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Series B, Seed rounds (top funding stages).
  • Majority of deals are located in Japan.
  • Strong thematic focus on Biotechnology, Medical, Health Care.
  • Led 1 rounds in the past year.

Stage Focus

  • Series A (45%)
  • Series B (27%)
  • Seed (18%)
  • Series D (9%)

Country Focus

  • Japan (100%)

Industry Focus

  • Biotechnology
  • Medical
  • Health Care
  • Artificial Intelligence (Ai)
  • Nursing And Residential Care
  • Manufacturing
  • Therapeutics
  • E-learning
  • Education
  • Language Learning
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does QB Capital frequently co-invest with?

RV
Remiges Ventures
North America, Massachusetts, United States, Cambridge
Co-Investments: 2
SMBC Venture Capital
SMBC Venture Capital
Asia, Tokyo, Japan, Tokyo
Co-Investments: 2
Nissay Capital
Nissay Capital
Asia, Tokyo, Japan, Tokyo
Co-Investments: 2
Mizuho Capital
Mizuho Capital
Asia, Tokyo, Japan, Tokyo
Co-Investments: 2
Newton Biocapital
Newton Biocapital
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 2
JIC Venture Growth Investments
JIC Venture Growth Investments
Asia, Tokyo, Japan, Marunouchi
Co-Investments: 2
Nippon Venture Capital
Nippon Venture Capital
Asia, Tokyo, Japan, Tokyo
Co-Investments: 3
Mitsubishi UFJ Capital
Mitsubishi UFJ Capital
Asia, Tokyo, Japan, Tokyo
Co-Investments: 2
DBJ Capital
DBJ Capital
Asia, Tokyo, Japan, Otemachi
Co-Investments: 2
DCI Partners
DCI Partners
Asia, Tokyo, Japan, Tokyo
Co-Investments: 2

Which angels does QB Capital often collaborate with?

RH
Robert Huang
North America, California, United States, San Diego
Shared Deals: 1

What are some of recent deals done by QB Capital?

Alumnote

Tokyo, Tokyo, Japan

Alumnote develops online alumni association management platforms that enable schools to manage their alumni associations and alumni.

AlumniConsultingSaaS
Series AJul 22, 2025
Amount Raised: $5,147,290
Equmenopolis

Tokyo, Tokyo, Japan

Equmenopolis is an information services company that specializes in conversational AI agent platforms and application developments.

Artificial Intelligence (AI)Information ServicesSoftware
SeedMar 10, 2025
Amount Raised: $1,699,778
Power Diamond Systems

Tokyo, Tokyo, Japan

Power Diamond Systems is a research and development firm that focuses on diamond semiconductor devices.

Business DevelopmentEnergyProduct ResearchSemiconductor
SeedNov 21, 2024
Amount Raised: $4,540,707
Japan Carbon Cycle Lab

Nishiku, Fukuoka, Japan

Japan Carbon Cycle Lab is a technology company that focuses on the research and development of CO2 capture and recycling techniques.

GreenTechLife ScienceRecyclingSustainability
Series AOct 8, 2024
Amount Raised: $2,700,089
Rege Nephro

Kyoto, Kyoto, Japan

Rege Nephro is a biotech company that specializes in R&D, production, and marketing of renal disease therapeutics.

BiotechnologyManufacturingMedicalRental
Series BOct 7, 2024
Amount Raised: $15,189,217
Zip Infrastructure

Tokyo, Tokyo, Japan

Zip Infrastructure engages in the manufacture and sale of transportation equipment and civil engineering business.

Civil EngineeringManufacturingSalesTransportation
Series ASep 2, 2024
Amount Raised: $2,112,436
Co-LABO MAKER

Sendai, Miyagi, Japan

Co-LABO MAKER is a sharing platform for experimental equipment, facilities, and technology.

Cloud Data ServicesCRMData Center Automation
Series AOct 11, 2023
Amount Raised: $1,274,834
Restore Vision

Tokyo, Tokyo, Japan

Restore Vision is a biotechnology company developing a visual restoration gene therapy for retinitis pigmentosa.

BiotechnologyHealth CareTherapeutics
Series AJun 5, 2023
Amount Raised: $9,109,510
LUCA Science

Tokyo, Tokyo, Japan

LUCA Science develops innovative treatments intended for mitochondrial and related diseases.

BiotechnologyHealth CarePharmaceutical
Series BJun 6, 2022
Amount Raised: $29,203,600
J-Pharma

Yokohama, Kanagawa, Japan

J-Pharma is biotechnology company mission is to creating and developing novel pharmaceuticals.

BiotechnologyMedicalNursing and Residential Care
Series DJul 30, 2020
Amount Raised: $16,678
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Most Active Investors Find InvestorsNewsletterPricing

Free tools

Pre-Money and Post-Money Valuation Calculator